ASX:LTPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
LTR Pharma Ltd
$0.510
+$0.020 (+4.08%)
Day Range
$0.495 – $0.535
52 Week Range
$0.310 – $0.810
Volume
170.80K
Avg Volume (10D)
223.44K
Market Cap
$92.71M
Price Chart
Market Statistics
Open$0.500
Previous Close$0.490
Day High$0.535
Day Low$0.495
52 Week High$0.810
52 Week Low$0.310
Valuation
Market Cap92.71M
Shares Outstanding181.78M
Price to Book3.31
Trading Activity
Volume170.80K
Value Traded87.71K
Bid$0.490 × 5,758
Ask$0.510 × 6,248
Performance
1 Day1.03%
5 Day-3.92%
13 Week25.64%
52 Week18.07%
YTD-31.94%
Technical Indicators
RSI (14)50.80
50-Day SMA$0.484
200-Day SMA$0.489
Latest News
Biotechnology
LTR Pharma Executes US Commercialisation Agreement with Shed DTC Platform
LTR Pharma inks US ROXUS deal with Shed; targets 150k units in year one via Mavrox telehealth—fast-acting 10-min onset.
Hot Topics
The Weekly Finger: On Green and Gold, and Oil and Gold
Oil inventories near lows despite Iran peace chatter; gold and oil diverge on the energy complex. Small Caps weekly market wrap on ASX stocks.
Biotechnology
LTR Pharma Signs Binding US Telehealth Term Sheet For ROXUS
LTR Pharma signs binding US telehealth term sheet with Shed Holdings for ROXUS via Mavrox; Definitive Agreements in 60 days to kickstart US commercialization.
Biotechnology
LTR Pharma Unveils Strong SPONTAN Data and Dual US Strategy
LTR Pharma reports SPONTAN PK: 5 mg intranasal Tmax 10 min vs 60 min oral; FDA 505(b)(2) pathway; dual US strategy; $24.1m cash, 2026 milestones